Valve-in-Valve TAVR: State-of-the-Art Review.

MedStar author(s):
Citation: Innovations: Technology & Techniques in Cardiothoracic & Vascular Surgery. 14(4):299-310, 2019 Aug.PMID: 31328655Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Aortic Valve Insufficiency/su [Surgery] | *Aortic Valve Stenosis/su [Surgery] | *Aortic Valve/su [Surgery] | *Bioprosthesis | *Heart Valve Prosthesis | *Postoperative Complications/su [Surgery] | *Prosthesis Failure | *Transcatheter Aortic Valve Replacement/mt [Methods] | Heart Valve Prosthesis Implantation | Humans | ReoperationYear: 2019Local holdings: Available online through MWHC library: Fall 2005 - presentISSN:
  • 1556-9845
Name of journal: Innovations (Philadelphia, Pa.)Abstract: An increasing number of surgically implanted bioprostheses will require re-intervention for structural valve deterioration. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) has become an alternative to reoperative surgery, currently approved for high-risk and inoperable patients. Challenges to the technique include higher rates of prosthesis-patient mismatch and coronary obstruction, compared to native valve TAVR. Herein, we review results of ViV TAVR and novel techniques to overcome the aforementioned challenges.All authors: Itsik Ben-Dor I, James Edelman J, Khan JM, Rogers T, Satler LF, Shults C, Thourani VH, Waksman ROriginally published: Innovations: Technology & Techniques in Cardiothoracic & Vascular Surgery. :1556984519858020, 2019 Jul 22Fiscal year: FY2020Digital Object Identifier: Date added to catalog: 2019-08-23
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 31328655 Available 31328655

Available online through MWHC library: Fall 2005 - present

An increasing number of surgically implanted bioprostheses will require re-intervention for structural valve deterioration. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) has become an alternative to reoperative surgery, currently approved for high-risk and inoperable patients. Challenges to the technique include higher rates of prosthesis-patient mismatch and coronary obstruction, compared to native valve TAVR. Herein, we review results of ViV TAVR and novel techniques to overcome the aforementioned challenges.

English

Powered by Koha